Pay in 4 interest-free payments of $5.72 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
The people who deserve extra attention usually include: Patients with a known history of diabetic retinopathy Patients with diabetic macular edema Patients with recently worsening retinopathy Patients with poor baseline glucose control who may experience a large A1c drop Patients starting semaglutide while already under retina treatment Patients with multiple high-risk features such as kidney disease, hypertension, or long-standing diabetes In contrast, a patient with type 2 diabetes, no known retinopathy, and a recent normal dilated exam may still need routine follow-upbut often not the same level of concern as someone with active retinal disease
These analyses underscore how GLP-1 medication, when combined with our engaging Companion app, can be a powerful driver of sustained progress. About Noom: Noom is the leading behavior change company, empowering everyone, everywhere to live better longer every day
4th Floor, Silverstream House, 45 Fitzroy Street, London Delikatny stabilny
Clin Gastroenterol Hepatol 2025;23:739-47.ArticlePubMed 22
